Stay updated on Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s UI/documentation footer revision number was updated from v3.5.2 to v3.5.3, indicating a minor system or display update rather than a change to the clinical trial record itself.
    Difference
    0.0%
    Check dated 2026-04-24T05:48:17.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the version history.
    Difference
    0.0%
    Check dated 2026-04-17T02:16:17.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    On 2026-03-30, Contacts/Locations and Study Status were added to the record; a version from 2025-12-10 was removed.
    Difference
    0.2%
    Check dated 2026-04-02T15:14:44.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added the latest revision entry (v3.5.0) and removed the previous revision (v3.4.3) from the study record history.
    Difference
    0.0%
    Check dated 2026-03-19T04:44:44.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added to the history and the previous revision (v3.4.2) was removed.
    Difference
    0.0%
    Check dated 2026-03-11T20:08:11.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.2 to the history and removed v3.4.1. This is an administrative update to the page’s history.
    Difference
    0.0%
    Check dated 2026-02-11T09:22:01.000Z thumbnail image

Stay in the know with updates to Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.